50 research outputs found
Open Access Publishing for English Language Learners
Open access publishing for English language learners reinforces the notion that valuable perspectives can be shared with the academic community before attaining an idealized threshold of English language proficiency. This report offers a description of three case studies that illustrate how open access repositories can be used to provide publishing opportunities for English language learners and stimulate interest in academic writing. Historical background on open scholarship publishing is included, along with implications for policy. The report expands on a panel discussion presented by the authors at the 2023 EnglishUSA Professional Development Conference
Least square polynomial spline approximation
Bounds are derived for both the L2- and L∞-norms of the error in approximating sufficiently smooth functions by polynomial splines using an integral least square technique based on the theory of orthogonal projection in real Hilbert space. Quadrature schemes for the approximate solution of this least square problem are examined and bounds for the error due to the use of such schemes are derived. The question of the consistency of such quadrature schemes with the least square error is investigated and asymptotic results are presented. Numerical results are also included.</p
‘whythe bendys a-bove hyr harnys’: An Investigation into the ‘Bend’ as a Part of Fifteenth-Century Military Clothing
Will Gene Patents Derail the Next-Generation of Genetic Technologies?: A Reassessment of the Evidence Suggests Not
Judge Bryson recently asserted in Association for Molecular Pathology v. US Patent and Trademark Office (dissenting-in-part) that human gene patents present a significant obstacle to the next generation of innovation in genetic medicine — multiplex tests and whole-genome sequencing. His concern over the impact of gene patents on genetic testing, which coincides with his position that certain gene patents should be declared patent ineligible, reflects a widely held misperception that 20% of human genes are patented in a manner that would necessarily result in infringement by whole genome sequencing and other forms of genetic testing. In fact, the myth that 20% of human genes are patented is based on a gross misreading of a single Policy Perspective article published in Science in 2005, and an unfortunate tendency among many commentators to consider gene patents in abstract terms that disregard the critical role of patent claims in limiting the scope of a patent owner\u27s right to exclude. Analysis of the claims of 533 of the of the patents identified in the Science article as covering human genes reveals that most do not include a single claim that would be infringed by whole genome sequencing and other forms of genetic testing. In fact, it seems quite likely that, were they to be litigated, few if any of these gene patents would be found to cover genetic testing or whole genome sequencing. Furthermore, a variety of practical limitations on enforcement and remedies appear to render it unlikely that the owners of these patents would be motivated to assert them against providers of whole genome sequencing and other next-generation diagnostic technologies in a manner that would impede progress in this area. There have been numerous instances in which fears that patents would harm biomedical research and medicine have proven in retrospect to have been greatly exaggerated, and history counsels against overreacting to the current controversy over gene patents. Ironically, it might be the case that the next generation of genetic diagnostic testing innovation will be adversely impacted not by too many patents, but by a lack of adequate patent protection
Foundation level Registered design law and practice notes
SIGLEAvailable from British Library Document Supply Centre- DSC:m03/17420 / BLDSC - British Library Document Supply Centre2. ed.GBUnited Kingdo